OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
-2.21%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$170M
AUM Growth
+$170M
(-11%)
Cap. Flow
-$12M
Cap. Flow
% of AUM
-7.07%
Top 10 Holdings %
Top 10 Hldgs %
56.85%
Holding
56
New
12
Increased
10
Reduced
12
Closed
16
Top Buys
| 1 |
Theravance Biopharma
TBPH
|
$5.04M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$4.97M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
$3.02M |
| 4 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$2.78M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$2.66M |
Top Sells
Sector Composition
| 1 | Healthcare | 95.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZGNX
51
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-220,000
| Closed | -$2.52M |
|
|
AFMD
52
DELISTED
Affimed
AFMD
| – | – |
-430,000
| Closed | -$1.2M |
|
|
AMRN
53
Amarin Corp
AMRN
$310M
| – | – |
-700,000
| Closed | -$2.23M |
|
54
Assertio
ASRT
$78.1M
| – | – |
-1,650
| Closed | -$41K |
|